Both studied patients have two R heterozygotic variants of MC1R, c.425G>A: p.(Arg142His) and c.451C>T: p.(Arg151Cys), conferring them not only melanoma risk, but also increased risk for BCC and SCC due to the R151C variant. This evidence concerns the gene MC1R and skin basal cell carcinoma.